nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—PTGS2—muscle cancer	0.312	1	CbGaD
Sulfasalazine—SLC46A1—Methotrexate—muscle cancer	0.187	0.349	CbGbCtD
Sulfasalazine—ABCG2—Dactinomycin—muscle cancer	0.0476	0.0887	CbGbCtD
Sulfasalazine—ABCC2—Vincristine—muscle cancer	0.0324	0.0604	CbGbCtD
Sulfasalazine—ABCC2—Etoposide—muscle cancer	0.0297	0.0554	CbGbCtD
Sulfasalazine—PTGS2—Etoposide—muscle cancer	0.0294	0.0547	CbGbCtD
Sulfasalazine—ABCG2—Vincristine—muscle cancer	0.0293	0.0546	CbGbCtD
Sulfasalazine—ABCG2—Etoposide—muscle cancer	0.0269	0.0501	CbGbCtD
Sulfasalazine—PTGS1—Etoposide—muscle cancer	0.0248	0.0462	CbGbCtD
Sulfasalazine—SLCO1B1—Methotrexate—muscle cancer	0.0223	0.0416	CbGbCtD
Sulfasalazine—ABCC2—Doxorubicin—muscle cancer	0.0203	0.0378	CbGbCtD
Sulfasalazine—ABCC2—Methotrexate—muscle cancer	0.0196	0.0366	CbGbCtD
Sulfasalazine—ABCG2—Doxorubicin—muscle cancer	0.0183	0.0342	CbGbCtD
Sulfasalazine—ABCG2—Methotrexate—muscle cancer	0.0177	0.0331	CbGbCtD
Sulfasalazine—CYP3A5—Vincristine—muscle cancer	0.0162	0.0303	CbGbCtD
Sulfasalazine—CYP3A5—Etoposide—muscle cancer	0.0149	0.0277	CbGbCtD
Sulfasalazine—SLC7A11—forelimb zeugopod—muscle cancer	0.0126	0.142	CbGeAlD
Sulfasalazine—TBXAS1—hindlimb—muscle cancer	0.00774	0.0877	CbGeAlD
Sulfasalazine—TBXAS1—appendage—muscle cancer	0.00664	0.0752	CbGeAlD
Sulfasalazine—PPARG—hindlimb—muscle cancer	0.00292	0.0331	CbGeAlD
Sulfasalazine—PPARG—appendage—muscle cancer	0.0025	0.0284	CbGeAlD
Sulfasalazine—PPARG—Teniposide—Etoposide—muscle cancer	0.00218	1	CbGdCrCtD
Sulfasalazine—ACAT1—smooth muscle tissue—muscle cancer	0.00207	0.0235	CbGeAlD
Sulfasalazine—ACAT1—renal system—muscle cancer	0.002	0.0226	CbGeAlD
Sulfasalazine—ACAT1—cardiac atrium—muscle cancer	0.00179	0.0203	CbGeAlD
Sulfasalazine—TBXAS1—smooth muscle tissue—muscle cancer	0.00173	0.0196	CbGeAlD
Sulfasalazine—ACAT1—tendon—muscle cancer	0.00156	0.0177	CbGeAlD
Sulfasalazine—ACAT1—bone marrow—muscle cancer	0.00151	0.0171	CbGeAlD
Sulfasalazine—PTGS2—hindlimb—muscle cancer	0.00149	0.0169	CbGeAlD
Sulfasalazine—CHUK—renal system—muscle cancer	0.00149	0.0169	CbGeAlD
Sulfasalazine—ACAT1—vagina—muscle cancer	0.00145	0.0164	CbGeAlD
Sulfasalazine—PLA2G1B—renal system—muscle cancer	0.0014	0.0158	CbGeAlD
Sulfasalazine—IKBKB—embryo—muscle cancer	0.00134	0.0151	CbGeAlD
Sulfasalazine—ACAT1—head—muscle cancer	0.00134	0.0151	CbGeAlD
Sulfasalazine—TBXAS1—tendon—muscle cancer	0.0013	0.0148	CbGeAlD
Sulfasalazine—ACAT1—testis—muscle cancer	0.00129	0.0146	CbGeAlD
Sulfasalazine—PTGS2—appendage—muscle cancer	0.00128	0.0145	CbGeAlD
Sulfasalazine—SLC7A11—smooth muscle tissue—muscle cancer	0.00127	0.0144	CbGeAlD
Sulfasalazine—TBXAS1—bone marrow—muscle cancer	0.00126	0.0143	CbGeAlD
Sulfasalazine—SLC7A11—renal system—muscle cancer	0.00122	0.0139	CbGeAlD
Sulfasalazine—SLC46A1—tendon—muscle cancer	0.00116	0.0132	CbGeAlD
Sulfasalazine—TBXAS1—head—muscle cancer	0.00112	0.0126	CbGeAlD
Sulfasalazine—TBXAS1—testis—muscle cancer	0.00108	0.0122	CbGeAlD
Sulfasalazine—IKBKB—smooth muscle tissue—muscle cancer	0.00105	0.0119	CbGeAlD
Sulfasalazine—CHUK—head—muscle cancer	0.000995	0.0113	CbGeAlD
Sulfasalazine—SLC46A1—head—muscle cancer	0.000995	0.0113	CbGeAlD
Sulfasalazine—Balsalazide—PTGS2—muscle cancer	0.00098	0.54	CrCbGaD
Sulfasalazine—SLC46A1—testis—muscle cancer	0.000961	0.0109	CbGeAlD
Sulfasalazine—CHUK—testis—muscle cancer	0.000961	0.0109	CbGeAlD
Sulfasalazine—PLA2G1B—head—muscle cancer	0.000935	0.0106	CbGeAlD
Sulfasalazine—PLA2G1B—testis—muscle cancer	0.000904	0.0102	CbGeAlD
Sulfasalazine—ALOX5—smooth muscle tissue—muscle cancer	0.00087	0.00986	CbGeAlD
Sulfasalazine—Olsalazine—PTGS2—muscle cancer	0.000833	0.46	CrCbGaD
Sulfasalazine—PPARG—embryo—muscle cancer	0.000831	0.00942	CbGeAlD
Sulfasalazine—SLC7A11—head—muscle cancer	0.000819	0.00928	CbGeAlD
Sulfasalazine—SLC7A11—testis—muscle cancer	0.000791	0.00897	CbGeAlD
Sulfasalazine—IKBKB—tendon—muscle cancer	0.000789	0.00894	CbGeAlD
Sulfasalazine—IKBKB—vagina—muscle cancer	0.000732	0.0083	CbGeAlD
Sulfasalazine—SLCO1B1—renal system—muscle cancer	0.000729	0.00826	CbGeAlD
Sulfasalazine—IKBKB—head—muscle cancer	0.000676	0.00766	CbGeAlD
Sulfasalazine—PPARG—smooth muscle tissue—muscle cancer	0.000653	0.0074	CbGeAlD
Sulfasalazine—IKBKB—testis—muscle cancer	0.000653	0.0074	CbGeAlD
Sulfasalazine—ALOX5—bone marrow—muscle cancer	0.000633	0.00718	CbGeAlD
Sulfasalazine—PPARG—renal system—muscle cancer	0.000629	0.00713	CbGeAlD
Sulfasalazine—ALOX5—head—muscle cancer	0.00056	0.00635	CbGeAlD
Sulfasalazine—ABCC2—renal system—muscle cancer	0.000553	0.00627	CbGeAlD
Sulfasalazine—ALOX5—testis—muscle cancer	0.000541	0.00614	CbGeAlD
Sulfasalazine—PPARG—tendon—muscle cancer	0.000491	0.00556	CbGeAlD
Sulfasalazine—PPARG—bone marrow—muscle cancer	0.000476	0.00539	CbGeAlD
Sulfasalazine—PPARG—vagina—muscle cancer	0.000456	0.00516	CbGeAlD
Sulfasalazine—ABCC2—tendon—muscle cancer	0.000432	0.00489	CbGeAlD
Sulfasalazine—PTGS2—embryo—muscle cancer	0.000425	0.00481	CbGeAlD
Sulfasalazine—PPARG—head—muscle cancer	0.000421	0.00477	CbGeAlD
Sulfasalazine—PPARG—testis—muscle cancer	0.000407	0.00461	CbGeAlD
Sulfasalazine—CYP3A5—renal system—muscle cancer	0.000374	0.00424	CbGeAlD
Sulfasalazine—ABCC2—testis—muscle cancer	0.000357	0.00405	CbGeAlD
Sulfasalazine—PTGS1—smooth muscle tissue—muscle cancer	0.000349	0.00396	CbGeAlD
Sulfasalazine—PTGS1—renal system—muscle cancer	0.000336	0.00381	CbGeAlD
Sulfasalazine—PTGS2—smooth muscle tissue—muscle cancer	0.000334	0.00378	CbGeAlD
Sulfasalazine—PTGS2—renal system—muscle cancer	0.000321	0.00364	CbGeAlD
Sulfasalazine—ABCG2—bone marrow—muscle cancer	0.000305	0.00345	CbGeAlD
Sulfasalazine—PTGS1—cardiac atrium—muscle cancer	0.000301	0.00341	CbGeAlD
Sulfasalazine—ABCG2—vagina—muscle cancer	0.000292	0.00331	CbGeAlD
Sulfasalazine—CYP3A5—vagina—muscle cancer	0.000271	0.00307	CbGeAlD
Sulfasalazine—PTGS1—tendon—muscle cancer	0.000262	0.00297	CbGeAlD
Sulfasalazine—ABCG2—testis—muscle cancer	0.000261	0.00295	CbGeAlD
Sulfasalazine—PTGS2—tendon—muscle cancer	0.000251	0.00284	CbGeAlD
Sulfasalazine—PTGS1—vagina—muscle cancer	0.000244	0.00276	CbGeAlD
Sulfasalazine—PTGS2—bone marrow—muscle cancer	0.000243	0.00275	CbGeAlD
Sulfasalazine—PTGS2—vagina—muscle cancer	0.000233	0.00264	CbGeAlD
Sulfasalazine—PTGS1—head—muscle cancer	0.000225	0.00255	CbGeAlD
Sulfasalazine—PTGS1—testis—muscle cancer	0.000217	0.00246	CbGeAlD
Sulfasalazine—PTGS2—head—muscle cancer	0.000215	0.00244	CbGeAlD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—FOXO4—muscle cancer	0.000164	0.00274	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—FOXO4—muscle cancer	0.000164	0.00274	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—FOXO4—muscle cancer	0.000163	0.00272	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—FOXO4—muscle cancer	0.000161	0.0027	CbGpPWpGaD
Sulfasalazine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—muscle cancer	0.000161	0.00268	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—FOXO4—muscle cancer	0.000161	0.00268	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—FOXO4—muscle cancer	0.000156	0.00261	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—ENO2—muscle cancer	0.000155	0.00259	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.000154	0.00258	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—FOXO4—muscle cancer	0.000152	0.00254	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000149	0.0025	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—FOXO4—muscle cancer	0.000149	0.00249	CbGpPWpGaD
Sulfasalazine—CHUK—PI-3K cascade—KIT—muscle cancer	0.000148	0.00248	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—FOXO1—muscle cancer	0.000145	0.00243	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—FOXO4—muscle cancer	0.000145	0.00243	CbGpPWpGaD
Sulfasalazine—CHUK—PI3K/AKT activation—KIT—muscle cancer	0.000145	0.00242	CbGpPWpGaD
Sulfasalazine—PTGS1—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000144	0.00241	CbGpPWpGaD
Sulfasalazine—CHUK—GAB1 signalosome—KIT—muscle cancer	0.000144	0.0024	CbGpPWpGaD
Sulfasalazine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—muscle cancer	0.00014	0.00235	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—FOXO1—muscle cancer	0.000139	0.00233	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—FOXO4—muscle cancer	0.000138	0.0023	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—FOXO1—muscle cancer	0.000138	0.0023	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—FOXO1—muscle cancer	0.000137	0.00229	CbGpPWpGaD
Sulfasalazine—CHUK—Apoptosis—CDKN2A—muscle cancer	0.000136	0.00228	CbGpPWpGaD
Sulfasalazine—CHUK—Apoptosis—MDM2—muscle cancer	0.000132	0.00221	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—FOXO1—muscle cancer	0.000131	0.00219	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—FOXO1—muscle cancer	0.00013	0.00218	CbGpPWpGaD
Sulfasalazine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—MDM2—muscle cancer	0.00013	0.00217	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—FOXO1—muscle cancer	0.000129	0.00217	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—FOXO1—muscle cancer	0.000129	0.00215	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—MED12—muscle cancer	0.000129	0.00215	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—FOXO1—muscle cancer	0.000127	0.00212	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000125	0.00209	CbGpPWpGaD
Sulfasalazine—ABCG2—Fluoropyrimidine Activity—TP53—muscle cancer	0.000124	0.00208	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis—CDKN2A—muscle cancer	0.000123	0.00206	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—ENO2—muscle cancer	0.000122	0.00205	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—IGF2—muscle cancer	0.000122	0.00204	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—FOXO1—muscle cancer	0.000121	0.00203	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—FOXO1—muscle cancer	0.000121	0.00203	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—FOXO1—muscle cancer	0.000121	0.00203	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.000121	0.00202	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—FOXO1—muscle cancer	0.00012	0.00201	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis—MDM2—muscle cancer	0.00012	0.002	CbGpPWpGaD
Sulfasalazine—IKBKB—Insulin Signaling—FOXO1—muscle cancer	0.000119	0.00199	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—FOXO1—muscle cancer	0.000119	0.00199	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—FOXO1—muscle cancer	0.000119	0.00198	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—FH—muscle cancer	0.000118	0.00197	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—ENO2—muscle cancer	0.000117	0.00196	CbGpPWpGaD
Sulfasalazine—CHUK—PI-3K cascade—MDM2—muscle cancer	0.000117	0.00195	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis Modulation and Signaling—CDKN2A—muscle cancer	0.000116	0.00194	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—FOXO1—muscle cancer	0.000115	0.00193	CbGpPWpGaD
Sulfasalazine—CHUK—PI3K/AKT activation—MDM2—muscle cancer	0.000114	0.00191	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—MYOD1—muscle cancer	0.000113	0.00189	CbGpPWpGaD
Sulfasalazine—CHUK—GAB1 signalosome—MDM2—muscle cancer	0.000113	0.00189	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—MED12—muscle cancer	0.000112	0.00188	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—FOXO1—muscle cancer	0.000112	0.00188	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—FOXO4—muscle cancer	0.000112	0.00187	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—HMGA1—muscle cancer	0.000111	0.00186	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—KIT—muscle cancer	0.000111	0.00185	CbGpPWpGaD
Sulfasalazine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—MDM2—muscle cancer	0.00011	0.00185	CbGpPWpGaD
Sulfasalazine—PPARG—Generic Transcription Pathway—MED12—muscle cancer	0.00011	0.00184	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—FOXO1—muscle cancer	0.00011	0.00184	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—FOXO1—muscle cancer	0.000107	0.0018	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—KIT—muscle cancer	0.000106	0.00177	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—KIT—muscle cancer	0.000104	0.00174	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—MED12—muscle cancer	0.000103	0.00173	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—ENO2—muscle cancer	0.000102	0.00171	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—FOXO1—muscle cancer	0.000102	0.0017	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—FOXO4—muscle cancer	0.000101	0.0017	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—FOXO4—muscle cancer	9.97e-05	0.00167	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—KIT—muscle cancer	9.96e-05	0.00167	CbGpPWpGaD
Sulfasalazine—PTGS2—C-MYB transcription factor network—KIT—muscle cancer	9.93e-05	0.00166	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—KIT—muscle cancer	9.91e-05	0.00166	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—KIT—muscle cancer	9.87e-05	0.00165	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—KIT—muscle cancer	9.82e-05	0.00164	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KIT—muscle cancer	9.68e-05	0.00162	CbGpPWpGaD
Sulfasalazine—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	9.62e-05	0.00161	CbGpPWpGaD
Sulfasalazine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	9.44e-05	0.00158	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—MED12—muscle cancer	9.38e-05	0.00157	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—MED12—muscle cancer	9.24e-05	0.00155	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—KIT—muscle cancer	9.24e-05	0.00154	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—KIT—muscle cancer	9.24e-05	0.00154	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—KIT—muscle cancer	9.24e-05	0.00154	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	9.17e-05	0.00153	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—KIT—muscle cancer	9.15e-05	0.00153	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—PTGS2—muscle cancer	9.15e-05	0.00153	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	9.15e-05	0.00153	CbGpPWpGaD
Sulfasalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—muscle cancer	9.08e-05	0.00152	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—KIT—muscle cancer	9.07e-05	0.00152	CbGpPWpGaD
Sulfasalazine—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—muscle cancer	9.04e-05	0.00151	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—KIT—muscle cancer	9.03e-05	0.00151	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD34—muscle cancer	9.01e-05	0.00151	CbGpPWpGaD
Sulfasalazine—CHUK—p75(NTR)-mediated signaling—TP53—muscle cancer	8.87e-05	0.00148	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KIT—muscle cancer	8.77e-05	0.00147	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—MDM2—muscle cancer	8.73e-05	0.00146	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—ENO2—muscle cancer	8.55e-05	0.00143	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—KIT—muscle cancer	8.55e-05	0.00143	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—KIT—muscle cancer	8.37e-05	0.0014	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—MDM2—muscle cancer	8.35e-05	0.0014	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—MDM2—muscle cancer	8.26e-05	0.00138	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—FOXO1—muscle cancer	8.26e-05	0.00138	CbGpPWpGaD
Sulfasalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—muscle cancer	8.23e-05	0.00138	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—MDM2—muscle cancer	8.22e-05	0.00137	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	8.18e-05	0.00137	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD34—muscle cancer	8.17e-05	0.00137	CbGpPWpGaD
Sulfasalazine—PTGS2—C-MYB transcription factor network—CDKN2A—muscle cancer	8.06e-05	0.00135	CbGpPWpGaD
Sulfasalazine—IKBKB—p75(NTR)-mediated signaling—TP53—muscle cancer	8.04e-05	0.00134	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—MDM2—muscle cancer	7.85e-05	0.00131	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—MDM2—muscle cancer	7.81e-05	0.00131	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—MDM2—muscle cancer	7.77e-05	0.0013	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—KIT—muscle cancer	7.75e-05	0.0013	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—MDM2—muscle cancer	7.73e-05	0.00129	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—MDM2—muscle cancer	7.62e-05	0.00127	CbGpPWpGaD
Sulfasalazine—CHUK—Apoptosis—TP53—muscle cancer	7.58e-05	0.00127	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—FOXO1—muscle cancer	7.49e-05	0.00125	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—FOXO1—muscle cancer	7.37e-05	0.00123	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—FH—muscle cancer	7.28e-05	0.00122	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	7.28e-05	0.00122	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—MDM2—muscle cancer	7.27e-05	0.00122	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	7.27e-05	0.00122	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—MDM2—muscle cancer	7.27e-05	0.00122	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—MDM2—muscle cancer	7.21e-05	0.00121	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—MDM2—muscle cancer	7.14e-05	0.00119	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—MDM2—muscle cancer	7.11e-05	0.00119	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KIDINS220—muscle cancer	7.09e-05	0.00119	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—MDM2—muscle cancer	6.91e-05	0.00116	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis—TP53—muscle cancer	6.87e-05	0.00115	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	6.84e-05	0.00114	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—MDM2—muscle cancer	6.73e-05	0.00113	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	6.69e-05	0.00112	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—MED12—muscle cancer	6.65e-05	0.00111	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	6.6e-05	0.0011	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	6.6e-05	0.0011	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	6.47e-05	0.00108	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis Modulation and Signaling—TP53—muscle cancer	6.44e-05	0.00108	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	6.44e-05	0.00108	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KIDINS220—muscle cancer	6.43e-05	0.00108	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—FOXO4—muscle cancer	6.38e-05	0.00107	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—KIT—muscle cancer	6.29e-05	0.00105	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	6.27e-05	0.00105	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—FOXO4—muscle cancer	6.12e-05	0.00102	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—MDM2—muscle cancer	6.1e-05	0.00102	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—ENO2—muscle cancer	6.06e-05	0.00101	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—FOXO4—muscle cancer	5.78e-05	0.000967	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—FH—muscle cancer	5.74e-05	0.000959	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—KIT—muscle cancer	5.71e-05	0.000954	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—FOXO1—muscle cancer	5.68e-05	0.00095	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—KIT—muscle cancer	5.61e-05	0.000939	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—FOXO4—muscle cancer	5.55e-05	0.000929	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD34—muscle cancer	5.46e-05	0.000914	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—PTGS2—muscle cancer	5.39e-05	0.000901	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—FH—muscle cancer	5.31e-05	0.000888	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—MED12—muscle cancer	5.29e-05	0.000885	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	5.2e-05	0.000869	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	5.14e-05	0.000859	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—VEGFA—muscle cancer	5.11e-05	0.000855	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—FH—muscle cancer	5.1e-05	0.000853	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—MDM2—muscle cancer	4.96e-05	0.000829	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD34—muscle cancer	4.95e-05	0.000829	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.74e-05	0.000793	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—TP53—muscle cancer	4.74e-05	0.000792	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—FOXO1—muscle cancer	4.71e-05	0.000788	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—FOXO1—muscle cancer	4.52e-05	0.000756	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—MDM2—muscle cancer	4.49e-05	0.000751	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—MDM2—muscle cancer	4.42e-05	0.000739	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—FOXO1—muscle cancer	4.27e-05	0.000714	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—PTGS2—muscle cancer	4.26e-05	0.000713	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—ENO2—muscle cancer	4.21e-05	0.000703	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—MED12—muscle cancer	4.12e-05	0.000688	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—FOXO1—muscle cancer	4.1e-05	0.000686	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—PTGS2—muscle cancer	4.08e-05	0.000683	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	4.05e-05	0.000678	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—FH—muscle cancer	4.05e-05	0.000677	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—TP53—muscle cancer	4.02e-05	0.000671	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TP53—muscle cancer	3.95e-05	0.00066	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	3.93e-05	0.000657	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—TP53—muscle cancer	3.86e-05	0.000646	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HMGA1—muscle cancer	3.82e-05	0.000639	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—FH—muscle cancer	3.81e-05	0.000636	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ENO2—muscle cancer	3.75e-05	0.000628	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—FOXO4—muscle cancer	3.71e-05	0.000621	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—KIT—muscle cancer	3.59e-05	0.0006	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—PTGS2—muscle cancer	3.57e-05	0.000597	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—KIT—muscle cancer	3.45e-05	0.000576	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—FOXO4—muscle cancer	3.43e-05	0.000573	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TP53—muscle cancer	3.42e-05	0.000572	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—FOXO4—muscle cancer	3.37e-05	0.000563	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—KIT—muscle cancer	3.25e-05	0.000544	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—MED12—muscle cancer	3.24e-05	0.000542	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—KIT—muscle cancer	3.12e-05	0.000523	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	3.08e-05	0.000515	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—MED12—muscle cancer	3e-05	0.000502	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—PTGS2—muscle cancer	2.98e-05	0.000498	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ENO2—muscle cancer	2.95e-05	0.000494	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.93e-05	0.000491	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—MED12—muscle cancer	2.88e-05	0.000482	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—MDM2—muscle cancer	2.83e-05	0.000473	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PTCH1—muscle cancer	2.79e-05	0.000467	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—FOXO1—muscle cancer	2.74e-05	0.000459	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ENO2—muscle cancer	2.74e-05	0.000458	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—MDM2—muscle cancer	2.71e-05	0.000454	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ENO2—muscle cancer	2.63e-05	0.00044	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—VEGFA—muscle cancer	2.59e-05	0.000433	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—MDM2—muscle cancer	2.56e-05	0.000429	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—FOXO1—muscle cancer	2.53e-05	0.000424	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PTCH1—muscle cancer	2.53e-05	0.000423	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ENO2—muscle cancer	2.49e-05	0.000417	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—FOXO1—muscle cancer	2.49e-05	0.000416	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—MDM2—muscle cancer	2.46e-05	0.000412	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—FOXO4—muscle cancer	2.4e-05	0.000402	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CNR1—muscle cancer	2.36e-05	0.000394	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	2.33e-05	0.000389	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.31e-05	0.000386	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—MED12—muscle cancer	2.29e-05	0.000383	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HMGA1—muscle cancer	2.26e-05	0.000379	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FOXO4—muscle cancer	2.18e-05	0.000364	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—MED12—muscle cancer	2.15e-05	0.00036	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CNR1—muscle cancer	2.14e-05	0.000357	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PTGS2—muscle cancer	2.11e-05	0.000353	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—KIT—muscle cancer	2.09e-05	0.00035	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ENO2—muscle cancer	2.09e-05	0.000349	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.06e-05	0.000344	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—FOXO4—muscle cancer	2.03e-05	0.00034	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ENO2—muscle cancer	1.96e-05	0.000328	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—KIT—muscle cancer	1.93e-05	0.000323	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IGF2—muscle cancer	1.93e-05	0.000322	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—KIT—muscle cancer	1.9e-05	0.000317	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—FOXO1—muscle cancer	1.77e-05	0.000297	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IGF2—muscle cancer	1.75e-05	0.000292	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MDM2—muscle cancer	1.65e-05	0.000275	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FOXO1—muscle cancer	1.61e-05	0.000269	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MDM2—muscle cancer	1.52e-05	0.000254	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—FOXO1—muscle cancer	1.5e-05	0.000251	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MDM2—muscle cancer	1.49e-05	0.00025	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PTGS2—muscle cancer	1.47e-05	0.000245	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KIT—muscle cancer	1.35e-05	0.000226	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTGS2—muscle cancer	1.31e-05	0.000219	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KIT—muscle cancer	1.23e-05	0.000205	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—KIT—muscle cancer	1.14e-05	0.000191	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MDM2—muscle cancer	1.06e-05	0.000178	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTGS2—muscle cancer	1.03e-05	0.000172	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MDM2—muscle cancer	9.65e-06	0.000161	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTGS2—muscle cancer	9.53e-06	0.000159	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTGS2—muscle cancer	9.16e-06	0.000153	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MDM2—muscle cancer	9e-06	0.000151	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—VEGFA—muscle cancer	8.08e-06	0.000135	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—VEGFA—muscle cancer	7.33e-06	0.000123	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTGS2—muscle cancer	6.83e-06	0.000114	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TP53—muscle cancer	6.11e-06	0.000102	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TP53—muscle cancer	5.54e-06	9.26e-05	CbGpPWpGaD
